Investigating Drug Resistance to Develop New Therapies Against Leukemia
1,742 views · Published 13 October 2015 · 2:45 · Indexed 12 November 2026
Channel: Children's Hospital Los Angeles · 2015 · Nonprofits & Activism
Yong-Mi Kim, MD, PhD, investigates resistance to chemotherapy and the resulting recurrence of cancer. Her research – using cutting-edge imaging approaches to study the interaction of drug resistant leukemia cells and their protective tumor microenvironment – is critical to understanding drug resistance and will lay the groundwork for developing effective, new therapies against leukemia.
More from this channel
-
0:35
A Brain Tumor Removed by Experts at CHLA
-
0:48
Helping Children with Sickle Cell Disease at CHLA
-
5:40
Helping Children with Sickle Cell Disease
-
2:11
Mitchell Geffner, MD, Division Chief, Endocrinology and Metabolism
-
1:29
Charles J. Gomer, PhD, Principal Investigator in The Saban Research Institute
-
2:13
Natasha Lepore, PhD, Prinicipal Investigator in The Saban Research Institute
-
1:00
Thank You Message for Ellen Pompeo
-
5:38
Associates & Affiliates Celebrate 100th Anniversary